TFR1_HUMAN - dbPTM
TFR1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TFR1_HUMAN
UniProt AC P02786
Protein Name Transferrin receptor protein 1
Gene Name TFRC
Organism Homo sapiens (Human).
Sequence Length 760
Subcellular Localization Cell membrane
Single-pass type II membrane protein . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
Transferrin receptor protein 1, serum form: Secreted .
Protein Description Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake. [PubMed: 26642240; (Microbial infection) Acts as a receptor for new-world arenaviruses: Guanarito, Junin and Machupo virus.]
Protein Sequence MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDEEENADNNTKANVTKPKRCSGSICYGTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLAGTESPVREEPGEDFPAARRLYWDDLKRKLSEKLDSTDFTGTIKLLNENSYVPREAGSQKDENLALYVENQFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQRDAWGPGAAKSGVGTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDFGNAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNGAFNETLFRNQLALATWTIQGAANALSGDVWDIDNEF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
7Phosphorylation-MMDQARSAFSNLFG
-CHHHHHHHHHHHHC
36.3621945579
10PhosphorylationDQARSAFSNLFGGEP
HHHHHHHHHHHCCCC
32.1321945579
19PhosphorylationLFGGEPLSYTRFSLA
HHCCCCCCEEEEEEE
34.8621945579
20PhosphorylationFGGEPLSYTRFSLAR
HCCCCCCEEEEEEEE
15.0425159151
21PhosphorylationGGEPLSYTRFSLARQ
CCCCCCEEEEEEEEE
23.1221945579
24PhosphorylationPLSYTRFSLARQVDG
CCCEEEEEEEEECCC
20.1610531064
34PhosphorylationRQVDGDNSHVEMKLA
EECCCCCCCEEEEEE
33.3823401153
39UbiquitinationDNSHVEMKLAVDEEE
CCCCEEEEEEECCHH
21.5721906983
52PhosphorylationEENADNNTKANVTKP
HHCCCCCCCCCCCCC
37.4825159151
53AcetylationENADNNTKANVTKPK
HCCCCCCCCCCCCCC
39.847960211
53UbiquitinationENADNNTKANVTKPK
HCCCCCCCCCCCCCC
39.8421906983
532-HydroxyisobutyrylationENADNNTKANVTKPK
HCCCCCCCCCCCCCC
39.84-
58UbiquitinationNTKANVTKPKRCSGS
CCCCCCCCCCCCCCC
44.2321906983
60UbiquitinationKANVTKPKRCSGSIC
CCCCCCCCCCCCCHH
68.54-
62S-palmitoylationNVTKPKRCSGSICYG
CCCCCCCCCCCHHHH
7.253582362
67S-palmitoylationKRCSGSICYGTIAVI
CCCCCCHHHHHHHHH
2.482398066
95AcetylationYCKGVEPKTECERLA
HHCCCCCCHHHHHHC
43.3726051181
104O-linked_GlycosylationECERLAGTESPVREE
HHHHHCCCCCCCCCC
27.901421756
104PhosphorylationECERLAGTESPVREE
HHHHHCCCCCCCCCC
27.9026434776
104O-linked_GlycosylationECERLAGTESPVREE
HHHHHCCCCCCCCCC
27.901421756
106PhosphorylationERLAGTESPVREEPG
HHHCCCCCCCCCCCC
28.6525159151
106O-linked_GlycosylationERLAGTESPVREEPG
HHHCCCCCCCCCCCC
28.65OGP
123PhosphorylationFPAARRLYWDDLKRK
CHHHHHHCHHHHHHH
12.6520068231
128AcetylationRLYWDDLKRKLSEKL
HHCHHHHHHHHHHHC
55.2527452117
128UbiquitinationRLYWDDLKRKLSEKL
HHCHHHHHHHHHHHC
55.25-
1282-HydroxyisobutyrylationRLYWDDLKRKLSEKL
HHCHHHHHHHHHHHC
55.25-
128SuccinylationRLYWDDLKRKLSEKL
HHCHHHHHHHHHHHC
55.2523954790
130UbiquitinationYWDDLKRKLSEKLDS
CHHHHHHHHHHHCCC
55.57-
132PhosphorylationDDLKRKLSEKLDSTD
HHHHHHHHHHCCCCC
35.4029457462
134UbiquitinationLKRKLSEKLDSTDFT
HHHHHHHHCCCCCCC
54.97-
1342-HydroxyisobutyrylationLKRKLSEKLDSTDFT
HHHHHHHHCCCCCCC
54.97-
143O-linked_GlycosylationDSTDFTGTIKLLNEN
CCCCCCCCEEECCCC
16.33OGP
145UbiquitinationTDFTGTIKLLNENSY
CCCCCCEEECCCCCC
46.9221906983
1452-HydroxyisobutyrylationTDFTGTIKLLNENSY
CCCCCCEEECCCCCC
46.92-
161UbiquitinationPREAGSQKDENLALY
CCCCCCCCCCCHHHH
69.5721906983
1612-HydroxyisobutyrylationPREAGSQKDENLALY
CCCCCCCCCCCHHHH
69.57-
168PhosphorylationKDENLALYVENQFRE
CCCCHHHHHHHHHHH
10.50-
177UbiquitinationENQFREFKLSKVWRD
HHHHHHHHCHHHHCC
47.28-
189UbiquitinationWRDQHFVKIQVKDSA
HCCCCEEEEEECCCC
26.86-
1892-HydroxyisobutyrylationWRDQHFVKIQVKDSA
HCCCCEEEEEECCCC
26.86-
189AcetylationWRDQHFVKIQVKDSA
HCCCCEEEEEECCCC
26.8627452117
193UbiquitinationHFVKIQVKDSAQNSV
CEEEEEECCCCCCEE
29.59-
195PhosphorylationVKIQVKDSAQNSVII
EEEEECCCCCCEEEE
26.4921712546
199PhosphorylationVKDSAQNSVIIVDKN
ECCCCCCEEEEEECC
11.5621712546
205UbiquitinationNSVIIVDKNGRLVYL
CEEEEEECCCCEEEE
50.8621906983
2052-HydroxyisobutyrylationNSVIIVDKNGRLVYL
CEEEEEECCCCEEEE
50.86-
211PhosphorylationDKNGRLVYLVENPGG
ECCCCEEEEEECCCC
15.0428152594
219PhosphorylationLVENPGGYVAYSKAA
EEECCCCEEEECEEE
6.4528152594
222PhosphorylationNPGGYVAYSKAATVT
CCCCEEEECEEEEEE
10.7228152594
223PhosphorylationPGGYVAYSKAATVTG
CCCEEEECEEEEEEE
13.1928152594
224UbiquitinationGGYVAYSKAATVTGK
CCEEEECEEEEEEEC
29.3921906983
231UbiquitinationKAATVTGKLVHANFG
EEEEEEECEEECCCC
37.66-
240UbiquitinationVHANFGTKKDFEDLY
EECCCCCCCCHHHHC
51.21-
2402-HydroxyisobutyrylationVHANFGTKKDFEDLY
EECCCCCCCCHHHHC
51.21-
241UbiquitinationHANFGTKKDFEDLYT
ECCCCCCCCHHHHCC
68.44-
248PhosphorylationKDFEDLYTPVNGSIV
CCHHHHCCCCCCEEE
28.2321601212
251N-linked_GlycosylationEDLYTPVNGSIVIVR
HHHCCCCCCEEEEEE
39.4310531064
251N-linked_GlycosylationEDLYTPVNGSIVIVR
HHHCCCCCCEEEEEE
39.4310531064
261UbiquitinationIVIVRAGKITFAEKV
EEEEECCEEEHHHHH
37.27-
2612-HydroxyisobutyrylationIVIVRAGKITFAEKV
EEEEECCEEEHHHHH
37.27-
282PhosphorylationNAIGVLIYMDQTKFP
CEEEEEEEECCCCCC
7.17-
286PhosphorylationVLIYMDQTKFPIVNA
EEEEECCCCCCEECE
30.32-
317N-linked_GlycosylationTPGFPSFNHTQFPPS
CCCCCCCCCCCCCCC
41.4510531064
317N-linked_GlycosylationTPGFPSFNHTQFPPS
CCCCCCCCCCCCCCC
41.4510531064
326PhosphorylationTQFPPSRSSGLPNIP
CCCCCCCCCCCCCCC
32.8523911959
327PhosphorylationQFPPSRSSGLPNIPV
CCCCCCCCCCCCCCH
43.1523911959
338PhosphorylationNIPVQTISRAAAEKL
CCCHHHHCHHHHHHH
21.1821712546
344UbiquitinationISRAAAEKLFGNMEG
HCHHHHHHHHCCCCC
44.37-
3442-HydroxyisobutyrylationISRAAAEKLFGNMEG
HCHHHHHHHHCCCCC
44.37-
353GlutathionylationFGNMEGDCPSDWKTD
HCCCCCCCCCCCCCC
5.2322555962
358UbiquitinationGDCPSDWKTDSTCRM
CCCCCCCCCCCCEEE
47.66-
371UbiquitinationRMVTSESKNVKLTVS
EEECCCCCCCEEEHH
62.80-
374UbiquitinationTSESKNVKLTVSNVL
CCCCCCCEEEHHHHH
48.08-
376PhosphorylationESKNVKLTVSNVLKE
CCCCCEEEHHHHHHH
19.0321955146
378PhosphorylationKNVKLTVSNVLKEIK
CCCEEEHHHHHHHHH
18.9121955146
382UbiquitinationLTVSNVLKEIKILNI
EEHHHHHHHHHHHCH
53.7821906983
382AcetylationLTVSNVLKEIKILNI
EEHHHHHHHHHHHCH
53.7827452117
385UbiquitinationSNVLKEIKILNIFGV
HHHHHHHHHHCHHEH
42.08-
394AcetylationLNIFGVIKGFVEPDH
HCHHEHHCCCCCCCE
43.8420167786
394UbiquitinationLNIFGVIKGFVEPDH
HCHHEHHCCCCCCCE
43.84-
402PhosphorylationGFVEPDHYVVVGAQR
CCCCCCEEEEEEEEC
11.4328152594
418AcetylationAWGPGAAKSGVGTAL
CCCCCHHHCCHHHHH
47.4020167786
418UbiquitinationAWGPGAAKSGVGTAL
CCCCCHHHCCHHHHH
47.4021906983
4182-HydroxyisobutyrylationAWGPGAAKSGVGTAL
CCCCCHHHCCHHHHH
47.40-
419PhosphorylationWGPGAAKSGVGTALL
CCCCHHHCCHHHHHH
33.7021712546
432SulfoxidationLLLKLAQMFSDMVLK
HHHHHHHHHHHHHHC
2.6321406390
4392-HydroxyisobutyrylationMFSDMVLKDGFQPSR
HHHHHHHCCCCCCCC
44.38-
480PhosphorylationSLHLKAFTYINLDKA
HCHHHEEEEEECCCH
28.4923286773
481PhosphorylationLHLKAFTYINLDKAV
CHHHEEEEEECCCHH
4.9523286773
486UbiquitinationFTYINLDKAVLGTSN
EEEEECCCHHHCCCC
43.49-
4862-HydroxyisobutyrylationFTYINLDKAVLGTSN
EEEEECCCHHHCCCC
43.49-
491PhosphorylationLDKAVLGTSNFKVSA
CCCHHHCCCCCEECC
19.1423286773
492PhosphorylationDKAVLGTSNFKVSAS
CCHHHCCCCCEECCC
38.1723286773
4952-HydroxyisobutyrylationVLGTSNFKVSASPLL
HHCCCCCEECCCHHH
39.26-
497PhosphorylationGTSNFKVSASPLLYT
CCCCCEECCCHHHHH
24.5023286773
499PhosphorylationSNFKVSASPLLYTLI
CCCEECCCHHHHHHH
14.4720068231
503PhosphorylationVSASPLLYTLIEKTM
ECCCHHHHHHHHHHH
13.7420068231
504PhosphorylationSASPLLYTLIEKTMQ
CCCHHHHHHHHHHHH
22.6428060719
508UbiquitinationLLYTLIEKTMQNVKH
HHHHHHHHHHHCCCC
42.16-
509PhosphorylationLYTLIEKTMQNVKHP
HHHHHHHHHHCCCCC
15.9321601212
514UbiquitinationEKTMQNVKHPVTGQF
HHHHHCCCCCCCCCE
50.14-
5142-HydroxyisobutyrylationEKTMQNVKHPVTGQF
HHHHHCCCCCCCCCE
50.14-
514AcetylationEKTMQNVKHPVTGQF
HHHHHCCCCCCCCCE
50.1421466224
518O-linked_GlycosylationQNVKHPVTGQFLYQD
HCCCCCCCCCEEECC
29.71OGP
523PhosphorylationPVTGQFLYQDSNWAS
CCCCCEEECCCCHHH
16.1528152594
531UbiquitinationQDSNWASKVEKLTLD
CCCCHHHHEEEEECC
46.8221906983
531AcetylationQDSNWASKVEKLTLD
CCCCHHHHEEEEECC
46.8227452117
534UbiquitinationNWASKVEKLTLDNAA
CHHHHEEEEECCCCH
50.16-
572PhosphorylationYLGTTMDTYKELIER
CCCCCHHHHHHHHHH
26.18-
573PhosphorylationLGTTMDTYKELIERI
CCCCHHHHHHHHHHH
9.75-
585UbiquitinationERIPELNKVARAAAE
HHHHHHHHHHHHHHH
50.31-
5852-HydroxyisobutyrylationERIPELNKVARAAAE
HHHHHHHHHHHHHHH
50.31-
611PhosphorylationDVELNLDYERYNSQL
CEEECCCHHHHHHHH
12.89-
614PhosphorylationLNLDYERYNSQLLSF
ECCCHHHHHHHHHHH
13.7628152594
616PhosphorylationLDYERYNSQLLSFVR
CCHHHHHHHHHHHHH
17.1721712546
620PhosphorylationRYNSQLLSFVRDLNQ
HHHHHHHHHHHHHHH
30.2321712546
654PhosphorylationGDFFRATSRLTTDFG
CCHHHHCCCEECCCC
25.0621601212
658PhosphorylationRATSRLTTDFGNAEK
HHCCCEECCCCCCHH
33.6417081983
665UbiquitinationTDFGNAEKTDRFVMK
CCCCCCHHHCHHHHH
54.0021906983
6652-HydroxyisobutyrylationTDFGNAEKTDRFVMK
CCCCCCHHHCHHHHH
54.00-
666PhosphorylationDFGNAEKTDRFVMKK
CCCCCHHHCHHHHHH
24.7421601212
683PhosphorylationDRVMRVEYHFLSPYV
HCEEEEEEEECCCCC
8.6028152594
687PhosphorylationRVEYHFLSPYVSPKE
EEEEEECCCCCCCCC
17.1628152594
689PhosphorylationEYHFLSPYVSPKESP
EEEECCCCCCCCCCC
15.3528152594
691PhosphorylationHFLSPYVSPKESPFR
EECCCCCCCCCCCCC
25.1426437602
693UbiquitinationLSPYVSPKESPFRHV
CCCCCCCCCCCCCCC
64.422190698
6932-HydroxyisobutyrylationLSPYVSPKESPFRHV
CCCCCCCCCCCCCCC
64.42-
717UbiquitinationPALLENLKLRKQNNG
HHHHHHHHHHHHCCC
58.80-
720UbiquitinationLENLKLRKQNNGAFN
HHHHHHHHHCCCCCC
68.74-
722N-linked_GlycosylationNLKLRKQNNGAFNET
HHHHHHHCCCCCCHH
52.5219349973
722N-linked_GlycosylationNLKLRKQNNGAFNET
HHHHHHHCCCCCCHH
52.5219349973
727N-linked_GlycosylationKQNNGAFNETLFRNQ
HHCCCCCCHHHHHCH
40.5910531064
727N-linked_GlycosylationKQNNGAFNETLFRNQ
HHCCCCCCHHHHHCH
40.597780197

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
20YPhosphorylationKinaseSRCP12931
PSP
24SPhosphorylationKinaseKPCAP17252
PhosphoELM
24SPhosphorylationKinasePRKCAP20444
GPS
24SPhosphorylationKinasePKC-FAMILY-GPS
24SPhosphorylationKinasePKC_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseFBXO6Q9NRD1
PMID:24658274
-KUbiquitinationE3 ubiquitin ligaseMARCHF2Q9P0N8
PMID:14722266
-KUbiquitinationE3 ubiquitin ligaseMARCHF1Q8TCQ1
PMID:14722266
-KUbiquitinationE3 ubiquitin ligaseMARCHF8Q5T0T0
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
62CPalmitoylation

3582362
62CPalmitoylation

3582362
67CPalmitoylation

3582362

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TFR1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HFE_HUMANHFEphysical
9465039
GBRAP_HUMANGABARAPphysical
11997026
AP2M_ARATHAT5G46630physical
17059402
TFR1_HUMANTFRCphysical
10531064
TRFE_HUMANTFphysical
11027676
HFE_HUMANHFEphysical
11027676
OPTN_HUMANOPTNphysical
20085643
HGS_HUMANHGSphysical
11988743
SH3B4_HUMANSH3BP4physical
16325581
B4GT1_HUMANB4GALT1physical
7744867
RANB9_HUMANRANBP9physical
14722085
RAB8A_HUMANRAB8Aphysical
22854040
ARFG1_HUMANARFGAP1physical
21499258
AP2B1_HUMANAP2B1physical
21499258

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TFR1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.";
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.;
Nat. Biotechnol. 27:378-386(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251, AND MASSSPECTROMETRY.
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251, AND MASSSPECTROMETRY.
O-linked Glycosylation
ReferencePubMed
"Identification of the O-linked glycosylation site of the humantransferrin receptor.";
Hayes G.R., Enns C.A., Lucas J.J.;
Glycobiology 2:355-359(1992).
Cited for: GLYCOSYLATION AT THR-104.
"Presence of O-linked oligosaccharide on a threonine residue in thehuman transferrin receptor.";
Do S.-I., Cummings R.D.;
Glycobiology 2:345-353(1992).
Cited for: GLYCOSYLATION AT THR-104.
Palmitoylation
ReferencePubMed
"Identification of the intermolecular disulfide bonds of the humantransferrin receptor and its lipid-attachment site.";
Jing S., Trowbridge I.S.;
EMBO J. 6:327-331(1987).
Cited for: PALMITOYLATION AT CYS-62.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY.

TOP